Loading company…
Senda Biosciences develops medicines using research into human, plant, and bacterial interactions.
Senda Biosciences uses computational biology and machine learning to identify molecular connections between organisms. Its discovery platform supports the development of therapeutic programs. Founded in 2017, the company is based in Cambridge, US. It raised USD 98 million in Series B funding in June 2021.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in